Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2004 | 1 |
2006 | 1 |
2024 | 0 |
Search Results
2 results
Results by year
Filters applied: . Clear all
Page 1
Comparison of 60-day mortality in hospitalized heart failure patients with versus without hypothermia.
Am J Cardiol. 2006 Dec 1;98(11):1485-8. doi: 10.1016/j.amjcard.2006.06.051. Epub 2006 Oct 16.
Am J Cardiol. 2006.
PMID: 17126655
Clinical Trial.
This study tested the hypothesis that low body temperature could predict short-term survival after discharge in patients hospitalized for HF. Data from the Acute and Chronic Therapeutic Impact of a Vasopressin Antagonist in Congestive Heart Failure (AC …
This study tested the hypothesis that low body temperature could predict short-term survival after discharge in patients hospitalized for HF …
Effects of tolvaptan, a vasopressin antagonist, in patients hospitalized with worsening heart failure: a randomized controlled trial.
Gheorghiade M, Gattis WA, O'Connor CM, Adams KF Jr, Elkayam U, Barbagelata A, Ghali JK, Benza RL, McGrew FA, Klapholz M, Ouyang J, Orlandi C; Acute and Chronic Therapeutic Impact of a Vasopressin Antagonist in Congestive Heart Failure (ACTIV in CHF) Investigators.
Gheorghiade M, et al.
JAMA. 2004 Apr 28;291(16):1963-71. doi: 10.1001/jama.291.16.1963.
JAMA. 2004.
PMID: 15113814
Clinical Trial.
CONTEXT: Nearly 1 million hospitalizations for chronic heart failure occur yearly in the United States, with most related to worsening systemic congestion. ...
CONTEXT: Nearly 1 million hospitalizations for chronic heart failure occur yearly in the United States, with most related to worsenin …
Item in Clipboard
Cite
Cite